Table 3 Distribution of HPV genotypes according to cytology abnormalities
NILM | AGC | ASC-H | ASC-US | LSIL | HSIL | |
|---|---|---|---|---|---|---|
No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | |
HR-HPV | ||||||
HPV16 | 379 (11.1) | 2 (40.0) | 6 (40.0) | 37 (15.7) | 34 (19.8) | 24 (40.7) |
HPV18 | 152 (4.4) | 0 (0.0) | 0 (0.0) | 13 (5.5) | 7 (4.1) | 8 (13.6) |
HPV31 | 141 (4.1) | 0 (0.0) | 0 (0.0) | 12 (5.1) | 4 (2.3) | 5 (8.5) |
HPV33 | 198 (5.8) | 1 (20.0) | 4 (26.7) | 11 (4.7) | 9 (5.2) | 7 (11.9) |
HPV35 | 60 (1.8) | 1 (20.0) | 0 (0.0) | 1 (0.4) | 2 (1.2) | 2 (3.4) |
HPV39 | 274 (8.0) | 0 (0.0) | 1 (6.7) | 1 4(5.9) | 7 (4.1) | 1 (1.7) |
HPV45 | 52 (1.5) | 1 (20.0) | 1 (6.7) | 5 (2.1) | 0 (0.0) | 1 (1.7) |
HPV51 | 306 (8.9) | 0 (0.0) | 0 (0.0) | 23 (9.8) | 25 (14.5) | 1 (1.7) |
HPV52 | 854 (24.9) | 1 (20.0) | 5 (33.3) | 65 (27.5) | 39 (22.7) | 7 (11.9) |
HPV53 | 313 (9.1) | 0 (0.0) | 2 (13.3) | 21 (8.9) | 22 (12.8) | 0 (0.0) |
HPV56 | 163 (4.8) | 0 (0.0) | 0 (0.0) | 19 (8.1) | 22 (12.8) | 0 (0.0) |
HPV58 | 463 (13.5) | 2 (40.0) | 4 (26.7) | 45 (19.1) | 32 (18.6) | 10 (17.0) |
HPV59 | 143 (4.2) | 0 (0.0) | 0 (0.0) | 12 (5.1) | 10 (5.8) | 0 (0.0) |
HPV66 | 230 (6.7) | 1 (20.0) | 1 (6.7) | 14 (5.9) | 16 (9.3) | 0 (0.0) |
HPV68 | 225 (6.6) | 1 (20.0) | 0 (0.0) | 17 (7.2) | 7 (4.1) | 0 (0.0) |
HPV73 | 18 (1.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
HPV82 | 21 (1.1) | 0 (0.0) | 0 (0.0) | 1 (0.8) | 1 (1.2) | 0 (0.0) |
HPV83 | 6 (0.3) | 0 (0.0) | 0 (0.0) | 2 (1.7) | 0 (0.0) | 0 (0.0) |
LR-HPV | ||||||
HPV6 | 118 (3.5) | 0 (0.0) | 1 (6.7) | 11 (4.7) | 6 (3.5) | 1 (1.7) |
HPV11 | 63 (1.8) | 0 (0.0) | 0 (0.0) | 4 (1.7) | 6 (3.5) | 0 (0.0) |
HPV42 | 222 (6.5) | 0 (0.0) | 0 (0.0) | 18 (7.6) | 15 (8.7) | 1 (1.7) |
HPV43 | 95 (2.8) | 0 (0.0) | 0 (0.0) | 11 (4.7) | 3 (1.7) | 0 (0.0) |
HPV44 | 162 (4.7) | 0 (0.0) | 0 (0 .0) | 5 (2.1) | 3 (1.7) | 1 (1.7) |
HPV81 | 124 (6.5) | 0 (0.0) | 0 (0.0) | 6 (5.0) | 5 (6.0) | 1 (4.0) |
CP8304 | 136 (8.9) | 0 (0.0) | 0 (0.0) | 10 (8.6) | 5 (5.7) | 1 (3.0) |